Aurobindo Pharma Ltd. ADR (ARBQY) Management on Q4 2022 Results
seekingalpha.com
finance
2022-05-31 11:50:20

Aurobindo Pharma Ltd. ADR (OTC:ARBQY) Q4 2022 Earnings Conference Call May 30, 2022 11:00 PM ET Company Participants Deepti Thakur - Investor Relations P.V. Ram Prasad Reddy - Chairman, Aurobindo, Pharma, USA K. Nityananda Reddy - Vice Chairman and Managing Director Santhanam Subramanian - Chief Financial Officer Yugandhar Puvvala - CEO of Eugia Pharma Specialties Limited Dr. Satakarni Makkapati - CEO of Aurobindo Biosimilars, Vaccines and Peptides businesses Conference Call Participants Neha Manpuria - JPMorgan Tarang Agarwal - Old Bridge Capital Kunal Randeria - Edelweiss Securities Limited Kunal Dhamesha - Emkay Global Financial Services Vishal Manchanda - Nirmal Bang Services Pvt Ltd Nishid Shah - Ambika Fincap Consultants Pvt Nitin Agarwal - DAM Capital Tushar Manudhane - Motilal Oswal Securities Limited Shyam Srinivasan - Goldman Sachs Operator Ladies and gentlemen, welcome to Quarter 4 FY '22 Earnings Conference Call of Aurobindo Pharma Limited.
